BRIVIACT
Generic: BRIVARACETAM
UCBManufacturer
INTRAVENOUSRoute
BRIVARACETAMActive Substance
2016-02-18Original Approval
BRIVIACT is FDA application NDA205837, sponsored by UCB INC. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Top Reported Reactions
1
SEIZURE
3,353 reports
2
OFF LABEL USE
1,195 reports
3
DRUG INEFFECTIVE
1,051 reports
4
FATIGUE
600 reports
5
THERAPY INTERRUPTED
545 reports
6
SOMNOLENCE
532 reports
7
OVERDOSE
516 reports
8
DIZZINESS
479 reports
9
PRODUCT AVAILABILITY ISSUE
403 reports
10
FALL
381 reports